These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9499247)

  • 61. External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation.
    Koontz BF; Lee WR
    Arch Esp Urol; 2011 Oct; 64(8):858-64. PubMed ID: 22052767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.
    Park S; Meng MV; Elkin EP; Speight JL; DuChane J; Carroll PR
    J Urol; 2005 Nov; 174(5):1802-7. PubMed ID: 16217291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan.
    Sasaki T; Nakamura K; Ogawa K; Onishi H; Okamoto A; Koizumi M; Shioyama Y; Mitsumori M; Teshima T;
    BJU Int; 2009 Nov; 104(10):1462-6. PubMed ID: 19522869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.
    Hashine K; Numata K; Azuma K; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2005 Nov; 35(11):655-9. PubMed ID: 16275680
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.
    Pellizzon AC; Nadalin W; Salvajoli JV; Fogaroli RC; Novaes PE; Maia MA; Ferrigno R
    Radiother Oncol; 2003 Feb; 66(2):167-72. PubMed ID: 12648788
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
    Merrick GS; Butler WM; Galbreath RW; Lief JH
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation.
    Igdem S; Abacioglu U; Cetin I; Alco G; Akgun Z; Sengoz M; Bekiroglu N; Turkan S; Okkan S
    J BUON; 2009; 14(4):629-34. PubMed ID: 20148454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.
    Bayley A; Rosewall T; Craig T; Bristow R; Chung P; Gospodarowicz M; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):477-83. PubMed ID: 19733014
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base.
    Amini A; Rusthoven CG; Jones BL; Armstrong H; Raben D; Kavanagh BD
    Urol Oncol; 2016 Apr; 34(4):165.e1-9. PubMed ID: 26699831
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy.
    Corn BW; Valicenti RK; Mulholland SG; Hyslop T; Gomella L
    Urology; 1998 May; 51(5):782-7. PubMed ID: 9610592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
    Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk.
    Braunstein LZ; Chen MH; Dosoretz DE; Salenius SA; Katin MJ; Nanda A; D'Amico AV
    Clin Genitourin Cancer; 2015 Dec; 13(6):555-61. PubMed ID: 26003267
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Limits of observational data in determining outcomes from cancer therapy.
    Giordano SH; Kuo YF; Duan Z; Hortobagyi GN; Freeman J; Goodwin JS
    Cancer; 2008 Jun; 112(11):2456-66. PubMed ID: 18428196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions.
    Røe K; Seierstad T; Kristian A; Mikalsen LT; Mælandsmo GM; van der Kogel AJ; Ree AH; Olsen DR
    Neoplasia; 2010 Oct; 12(10):818-25. PubMed ID: 20927320
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Late complications after radiotherapy for prostate cancer.
    Jung H; Beck-Bornholdt HP; Svoboda V; Alberti W; Herrmann T
    Strahlenther Onkol; 2012 Nov; 188(11):965-74. PubMed ID: 23053139
    [TBL] [Abstract][Full Text] [Related]  

  • 78. External beam radiotherapy for carcinoma of the prostate: a retrospective study.
    Mithal NP; Hoskin PJ
    Clin Oncol (R Coll Radiol); 1993; 5(5):297-301. PubMed ID: 8305338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endocrine therapy for recurrence after definitive radiotherapy in patients with prostate cancer.
    Furuya Y; Akakura K; Tanaka M; Ichikawa T; Igarashi T; Murakami S; Ito H
    Int J Urol; 2001 May; 8(5):222-6. PubMed ID: 11328422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients.
    Huguenin PU; Bitterli M; Lütolf UM; Bernhard J; Glanzmann C
    Strahlenther Onkol; 1999 Nov; 175(11):554-8. PubMed ID: 10584125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.